Is pharmacogenomics a reality? Challenges and oppurtunities for India.
作者信息
Banerjee Moinak
机构信息
Human Molecular Genetics Laboratory, Rajiv Gandhi Center for Biotechnology, Trivandrum, Kerala, India.
出版信息
Indian J Hum Genet. 2011 May;17 Suppl 1(Suppl 1):S1-3. doi: 10.4103/0971-6866.80350.
Abstract
摘要
相似文献
1
Is pharmacogenomics a reality? Challenges and oppurtunities for India.
Indian J Hum Genet. 2011 May;17 Suppl 1(Suppl 1):S1-3. doi: 10.4103/0971-6866.80350.
2
A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Qatar.
J Eval Clin Pract. 2015 Aug;21(4):703-9. doi: 10.1111/jep.12372. Epub 2015 Apr 30.
3
Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.
J Oncol Pharm Pract. 2020 Sep;26(6):1374-1381. doi: 10.1177/1078155219896395. Epub 2020 Jan 14.
4
The implementation of pharmacogenomics into UK general practice: a qualitative study exploring barriers, challenges and opportunities.
J Community Genet. 2020 Jul;11(3):269-277. doi: 10.1007/s12687-020-00468-2. Epub 2020 May 28.
5
African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa.
AAS Open Res. 2019 Jun 4;2:19. doi: 10.12688/aasopenres.12965.1. eCollection 2019.
6
A case for pharmacogenomics in management of cardiac arrhythmias.
Indian Pacing Electrophysiol J. 2012 Mar;12(2):54-64. doi: 10.1016/s0972-6292(16)30480-6. Epub 2012 Apr 30.
7
Challenges and opportunities in implementing pharmacogenomics testing in the clinics.
Per Med. 2012 Aug;9(6):609-619. doi: 10.2217/pme.12.64.
8
Personalized medicine: reality and reality checks.
Ann Pharmacother. 2009 May;43(5):963-6. doi: 10.1345/aph.1M065.
9
On pharmacogenomics in pharmacy benefit management.
Pharmacotherapy. 2012 Feb;32(2):103-11. doi: 10.1002/PHAR.1039. Epub 2012 Jan 24.
10
personalized medicine and pharmacogenomics: ethical and social challenges.
Per Med. 2005 Mar;2(1):29-35. doi: 10.1517/17410541.2.1.29.
引用本文的文献
1
Cataloging Actionable Pharmacogenomic Variants for Indian Clinical Practice: A Scoping Review.
J Xenobiot. 2025 Jul 1;15(4):101. doi: 10.3390/jox15040101.
2
Genetic diversity of 'Very Important Pharmacogenes' in two South-Asian populations.
PeerJ. 2021 Nov 10;9:e12294. doi: 10.7717/peerj.12294. eCollection 2021.
3
Pharmacogenomics, Theranostics and Personalized Medicine - the complexities of clinical trials: challenges in the developing world.
Appl Transl Genom. 2013 May 14;2:17-21. doi: 10.1016/j.atg.2013.05.002. eCollection 2013 Dec 1.
4
Immunophenotyping of normal individuals classified on the basis of human dosha prakriti.
J Ayurveda Integr Med. 2014 Jan;5(1):43-9. doi: 10.4103/0975-9476.128857.
本文引用的文献
1
Survey of US public attitudes toward pharmacogenetic testing.
Pharmacogenomics J. 2012 Jun;12(3):197-204. doi: 10.1038/tpj.2011.1. Epub 2011 Feb 15.
2
Clinical assessment incorporating a personal genome.
Lancet. 2010 May 1;375(9725):1525-35. doi: 10.1016/S0140-6736(10)60452-7.
3
Reconstructing Indian population history.
Nature. 2009 Sep 24;461(7263):489-94. doi: 10.1038/nature08365.
4
The microeconomics of personalized medicine: today's challenge and tomorrow's promise.
Nat Rev Drug Discov. 2009 Apr;8(4):279-86. doi: 10.1038/nrd2825. Epub 2009 Mar 20.
5
Genomic inferences on peopling of south Asia.
Curr Opin Genet Dev. 2008 Jun;18(3):280-4. doi: 10.1016/j.gde.2008.07.003. Epub 2008 Aug 11.
6
A crypto-Dravidian origin for the nontribal communities of South India based on human leukocyte antigen class I diversity.
Tissue Antigens. 2006 Sep;68(3):225-34. doi: 10.1111/j.1399-0039.2006.00652.x.
7
The Indian Genome Variation database (IGVdb): a project overview.
Hum Genet. 2005 Oct;118(1):1-11. doi: 10.1007/s00439-005-0009-9. Epub 2005 Aug 25.
8
Pharmacogenetics and geographical ancestry: implications for drug development and global health.
Nat Rev Genet. 2005 Mar;6(3):241-6. doi: 10.1038/nrg1559.
9
High-throughput screening in academia: the Harvard experience.
J Biomol Screen. 2003 Dec;8(6):615-9. doi: 10.1177/1087057103260741.
10
Pharmacogenomics in schizophrenia: the quest for individualized therapy.
Hum Mol Genet. 2002 Oct 1;11(20):2517-30. doi: 10.1093/hmg/11.20.2517.
Zotero 插件